KDIGO 2022 Clinical Practice Guideline for diabetes management in chronic kidney disease
Whilst sweating is not listed as a common side effect in official prescribing information for GLP-1 medications such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), or liraglutide (Victoza, Saxenda), several indirect factors may explain this phenomenon
Semaglutide GLP-1 is a medication often used in our clinic to aid in weight loss by regulating appetite and insulin levels, making it an effective option for many of our patients
It performs on a new level compared to other anti-obesity medications as it has been proven to reduce hunger, food cravings, food intake, and preference for high-fat foods
A look at the fascinating science of how the medication works could also go a long way to changing how Americans think about this disease